Sky News
@skynews·9.3M subscribers·76.1K videos
New Alzheimer's drug is first 'to target the root cause'
Posted
November 30, 2022
Views
23,455
Likes
71
Comments
28
Engagement
0.42%
November 30, 2022
23,455
71
28
0.42%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
2:43Now PlayingKay Burley is joined by Research Information Manager at the Alzheimer's Society, Sian Gregory, who predicted that by 2025 their drug "could benefit at least 106,000 people in the UK".
The new drug called Lecanemab could slow the debilitating symptoms of the disease.
#skynews #alzheimer #medicine
SUBSCRIBE to our YouTube channel for more videos
Follow us on Twitter
Like us on Facebook
Follow us on Instagram
Follow us on TikTok
For more content go to and download our apps
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí
Sky News videos are also available in German here/Hier können Sie außerdem Sky NewsVideos auf Deutsch finden
To enquire about licensing Sky News content, you can find more information here
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
